ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
AcroBioSystems
カタログNo.
HL1-H82Eb
製品名称
Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified)
タンパク質名
HLA-A*0201 & B2M & WT-1 (RMFPNAPYL)
Species
Human
HOST
HEK293
25ug: 32,200 円
お問い合わせ
200ug: 182,300 円
お問い合わせ

Overview

Synonyms -
Characteristics Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein is produced by co-expression of HLA-A*02:01 and B2M loaded with WT-1 peptide.
This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag?), and it is not biotinylated.
The protein has a calculated MW of 36.3 kDa and 11.7 kDa. The protein migrates as 40-43 kDa and 10 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level N/A
Purity 90%
Description Wilms tumor gene 1 (WT1),is an attractive target antigen for leukemia and solid cancer. WT1-specific adoptive immunotherapy has developed for tumor treatment in recent years. WT1 has been proved wildly expressed in breast, colon and ovarian cancer. It participates in cell growth, differentiation and apoptosis regulation. The Human HLA-A*0201 WT-1 (RMFPNAPYL) complex Protein is a complex of HLA-A*0201 of the MHC Class I, B2M and RMFPNAPYL peptide of the WT-1.
Reference 2207
URL https://www.acrobiosystems.com/products/protein/hla-a-0201-b2m-wt-1-rmfpnapyl-human-hl1-h82eb

お問い合わせリスト(-)

お問い合わせフォーム